
Sandhya Suresh
@Sandyrvsdav
Followers
2K
Following
4K
Media
179
Statuses
2K
Nephrologist @SRIHER_Official #NSMC2022 Mysteries of Medicine❤️🩺. MMC CMC MPUH. @ISNKidneycare @WomenNeph_India SoMe team. Sport lover🏏🎾
Chennai, India
Joined July 2012
As a nephrologist, I see the burden of CKD every day. Yet it's often invisible in public health conversations. With 850M affected worldwide, kidney health must be a global priority. Proud of @ISNkidneycare’s advocacy at #WHA78 👏.#KidneyHealthMatters #ThisIsISN #PublicHealth #UHC.
🌍 The International Society of Nephrology is in Geneva this week for the 78th World Health Assembly (#WHA78), continuing to champion kidney health as a global priority through high-level advocacy and collaboration. 🗣️ ISN is meeting with government representatives to better
0
2
13
RT @ISNeducation: 24/n #ECNeph @myadla @Dilushiwijay @ISNkidneycare @krithicism @shubharthikar .When to suspect malignancy in GN . https://t….
0
9
0
RT @ISNeducation: 12/n #ECNeph @ISNkidneycare @myadla @Dilushiwijay @shubharthikar .A recent #CKJ publication : evaluation for routine canc….
0
16
0
RT @ISNeducation: 3b/n #ECNeph @ISNkidneycare @myadla @Dilushiwijay Check infographic by @sibgokcay - May 2022 session . .
0
9
0
@WomenNeph_india @KajareeG @krithicism @SwarnalathaGud2 Combination therapy - no miracle cure!.🔬 OVERCOME Trial.💊 Combo: Colistin + Meropenem vs Colistin alone.📈 464 pts, 7 countries.👉 No significant mortality benefit of combo over mono. 🦠 Predominantly XDR Acinetobacter baumannii
0
4
5
@WomenNeph_india @KajareeG @krithicism @SwarnalathaGud2 💡 Carbapenem-resistant Pseudomonas: Treatment options.✅ Colistin.✅ Aminoglycosides.✅ Fosfomycin (high dose).✅ Ceftazidime-Avibactam (if directly sensitive).📌 Susceptibility matters!
1
3
4
@WomenNeph_india @KajareeG @krithicism @SwarnalathaGud2 🧠 Remember.🚫 Ceftazidime-Avibactam is ineffective against CRAB.✅ Try:.Colistin.Sulbactam (high dose).Fosfomycin.Aminoglycosides.Co-trimoxazole
1
2
3
@WomenNeph_india @KajareeG @krithicism @SwarnalathaGud2 💊 Fosfomycin for MDR bugs.📌 No RCT data on monotherapy.✅ Used in combo & rescue settings.🧪 Combos: polymyxins, tigecycline, cefta-AVI, meropenem.🧬 Potential in pan-resistant E. coli.⚠️ Still inconclusive
1
2
3
@WomenNeph_india @KajareeG @krithicism @SwarnalathaGud2 🧪 Ceftazidime-Avibactam + Aztreonam.💡 Aztreonam resists MBL hydrolysis.🧬 Ceftazidime-AVI inhibits other β-lactamases.💥 Combo = complete coverage against complex resistance.✅ Promising for MBL + ESBL/CRE infections
1
3
4
RT @KajareeG: 🦠 Infections post KT are dreaded complications .🔎Tune into today's @WomenNeph_india webinar.At 7 pm IST.⏭️.
0
5
0
RT @WINICON2025: 🩺✨ Inviting you all to join us for the upcoming WIN ICON 2025 . 📍 Chennai.📅 August 30–31, 2025.🧠 Learn 💬 Connect🌱 Lead.Don….
0
6
0
RT @WINICON2025: 🌟Abstract Submissions Now Open!🌟.Join us in the vibrant city of Chennai for WIN-ICON 2025, the 4th Annual Conference of Wo….
0
1
0
RT @WINICON2025: 🎉 Save the Date!.📍 Chennai | 🗓️ Aug 30–31, 2025.Join us at #WINICON2025 a celebration of camaraderie, collaboration & cutt….
0
5
0